The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarget Healthc. Regulatory News (THRL)

Share Price Information for Target Healthc. (THRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.40
Bid: 77.20
Ask: 77.50
Change: -0.80 (-1.02%)
Spread: 0.30 (0.389%)
Open: 79.00
High: 79.00
Low: 77.20
Prev. Close: 78.20
THRL Live PriceLast checked at -
Target Healthcare REIT is an Investment Trust

To provide ordinary shareholders with an attractive level of income with the potential for capital and income growth from investing in best-in-class care home assets with attractive financial characteristics.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Net Asset Value announcement

5 Aug 2015 07:00

RNS Number : 1051V
Target Healthcare REIT Limited
05 August 2015
 



To: RNS Company Announcements

Date: 5 August 2015

Company: Target Healthcare REIT Limited

Subject: Net Asset Value

 

Net Asset Value

 

The Group announces that its unaudited EPRA NAV per share as at 30 June 2015 was 98.0 pence. The Group's care home assets held for the three month period increased in value by 1.7%. This valuation growth contributed towards a net increase of 1.7% in the EPRA NAV per share as at 30 June 2015 as analysed in the table below.

 

As at 30 June 2015 the Group owned twenty-eight care homes with a market value of £143.7 million. The valuation of the homes is based on the external valuation of the Company's property portfolio prepared by Colliers International.

 

The EPRA NAV includes income and no provision for an accrued dividend has been made.

 

The next quarterly valuation of the property portfolio will be conducted by Colliers International during September 2015 and the NAV per share as at 30 September 2015 will be announced in October 2015.

 

 

Analysis of movement in EPRA NAV

 

The following table provides an analysis of the movement in the unaudited EPRA NAV per share for the period from 31 March 2015 to 30 June 2015:

 

Pence per share

EPRA NAV per share as at 31 March 2015

96.4

 

Property revaluation

 

1.8

Movement in revenue reserve

1.4

Movement due to third interim dividend payment to 31 March 2015

(1.6)

EPRA NAV per share as at 30 June 2015

98.0

Percentage change in the 3 month period

1.7%

 

 

Highlights

 

- Dividends

 

The Company paid its third interim dividend for the year to 30 June 2015, in respect of the period from 1 January 2015 to 31 March 2015, of 1.53 pence per share on 29 May 2015. This reflects an annualised payment of 6.12 pence per share and a dividend yield of 5.6% based on a share price of 110.0 pence as at 4 August 2015.

 

 

- Portfolio

 

As at 30 June 2015 the Group owned twenty-eight care homes with a market value of £143.7 million. On a like-for-like basis the portfolio has increased in value by 1.7% reflecting an element of yield compression across individual assets as the underlying trading performance of the homes mature and uplifts from rent reviews on 7 properties. These rent reviews provided a 2% increase per property, and a like-for-like increase to portfolio passing rent of 0.6%.

 

As at 30 June 2015, the portfolio had an EPRA net initial yield of 7.1% (based on contractual net income) and an annualised rent roll of £11.0m with the weighted-average unexpired lease term of 29.5 years.

 

During June 2015 the Group exchanged contracts to acquire a purpose-built care home in Kingston-Upon-Hull for approximately £6.2 million including acquisition costs. The tenant is Arrow Healthcare Limited who will engage the services of specialist elderly care home operator, Healthcare Management Solutions, to operate the home under a management services agreement. The rent payable under the lease comprises a base rent subject to annual RPI-linked uplifts and incorporating a cap and collar, as well as a share in the profits of the care home. The income to the Group is forecast to represent a net initial yield in excess of 7%.

 

 

- Pipeline

 

The Group continues to be acquisitive, focusing on its strategy of acquiring high quality assets with favourable local dynamics and sustainable rental levels. Hence, in addition to the exchanged property in Kingston-Upon-Hull, the Group is currently actively evaluating a pipeline of near-term opportunities worth approximately £60 million, of which opportunities worth approximately £16 million have agreed heads of terms in place.

 

 

A placing programme, established through the Company's prospectus dated 5 September 2014, enables the Company to issue up to a further 52,923,403 new shares over the period to 4 September 2015 with such shares being issued at a premium to the prevailing NAV sufficient to cover the costs associated with the issue.

 

 

As such, through its Investment Manager and broker, the Company will continue to engage and consult with existing and prospective new shareholders in connection with achieving accretive and disciplined growth via the placing programme over the period to September 2015.

 

The Company currently has 142,298,226 ordinary shares in issue.

 

 

Kenneth MacKenzie, Managing Partner of Target Advisers LLP, commented on the Group's activity during the period:

 

'The portfolio continues to perform strongly with further capital growth and rental growth which is ahead of inflation. Across the sector there was some slowing in single asset deals coming to market around the time of the general election, and some of our deals in the pipeline have taken longer to progress to completion, but we are again seeing good opportunities to continue investing to meet our objectives.'

 

 

Enquiries:

 

Kenneth MacKenzie

Target Advisers

01786 406 581

 

Stifel Nicolaus Europe Limited

Mark Young, Roger Clarke, Neil Winward

020 7710 7600

 

Fiona Harris/Sam Emery

Quill PR

020 7466 5058 / 020 7466 5056

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVQZLFBEVFXBBL
Date   Source Headline
28th Mar 20242:30 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSHalf-year Report
8th Mar 20249:00 amRNSInvestor Presentation via Investor Meet Company
22nd Feb 20247:00 amRNSNotice of Half Year Results
6th Feb 20242:00 pmEQSEdison issues update on Target Healthcare REIT (THRL): Rent cover at a high and fully covered DPS
1st Feb 20247:00 amRNSNet Asset Value, Corporate Update & Dividend
30th Nov 20237:00 amRNSResult of AGM
7th Nov 202310:16 amEQSEdison issues outlook on Target Healthcare REIT (THRL): DPS growth from a sustainable base
1st Nov 20237:00 amRNSNet Asset Value, Corporate Update & Dividend
31st Oct 20235:30 pmRNSAnnual Financial Report
10th Oct 20237:00 amRNSFinal Results
4th Oct 20232:00 pmRNSNotice of Full Year Results
11th Aug 20238:09 amRNSEdison issues update on Target Healthcare REIT
2nd Aug 20237:00 amRNSNet Asset Value, Corporate Update & Dividend
3rd May 20237:00 amRNSNet Asset Value, Corporate Update & Dividend
28th Mar 202311:37 amRNSDirector/PDMR Shareholding
27th Mar 20237:00 amRNSDisposal of four care homes in Northern Ireland
27th Mar 20237:00 amRNSHalf-year Report
23rd Mar 20237:00 amRNSNotice of Half Year Results
17th Feb 202311:08 amRNSHolding(s) in Company
2nd Feb 20237:00 amRNSNet Asset Value, Corporate Update & Dividend
7th Dec 20227:00 amRNSDirectorate Change
6th Dec 20222:30 pmRNSResult of AGM
21st Nov 20225:07 pmRNSHolding(s) in Company
21st Nov 20227:00 amRNSHolding(s) in Company
21st Nov 20227:00 amRNSHolding(s) in Company
8th Nov 20225:47 pmRNSAnnual Financial Report
2nd Nov 20227:00 amRNSNet Asset Value, Corporate Update & Dividend
28th Oct 20229:17 amRNSHolding(s) in Company
17th Oct 20229:20 amRNSHolding(s) in Company
12th Oct 20227:00 amRNSFinal Results
12th Oct 20227:00 amRNSDirectorate Change
1st Sep 20227:00 amRNSPortfolio Update
4th Aug 20227:00 amRNSNet Asset Value, Corporate Update & Dividend
22nd Jun 20227:00 amRNSHolding(s) in Company
9th Jun 20226:01 pmRNSHolding(s) in Company
9th Jun 20227:00 amRNSInclusion in FTSE 250 Index
6th Jun 20229:42 amRNSHolding(s) in Company
9th May 202211:43 amRNSDirector/PDMR Shareholding
5th May 202210:01 amRNSHolding(s) in Company
5th May 20227:00 amRNSNet Asset Value, Corporate Update & Dividend
3rd May 20229:21 amRNSHolding(s) in Company
16th Mar 20227:00 amRNSHalf-year Report
10th Mar 20227:00 amRNSNotice of Half Year Results
1st Feb 20227:00 amRNSDirectorate Change
27th Jan 20227:00 amRNSNet Asset Value, Corporate Update & Dividend
20th Dec 20217:00 amRNSCompletion of Portfolio Acquisition
15th Dec 20217:00 amRNSResult of AGM
30th Nov 20217:00 amRNSNew long-term institutional debt facility
10th Nov 20219:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.